A B C
08:00-09:00 Registration
09:00-0910 Opening remarks : ÇÐȸÀå
09:10-10:00 Symposium I : safety of living donors
10:00-11:00 Plenary lecture
Safety of living organ donors
11:00-11:20 Coffee break
11:20-12:30 Symposium II: Updates in Transplantation Related Infection
12:30-12:50 General assembly
12:50-13:50 Luncheon Symposium
13:50-14:00 Break
14:00-15:15 Concurrent symposium I
Kidney Transplanation
Concurrent symposium II
Liver Transplanation
Concurrent symposium III
Pathology and diagnostic immunology
15:15-15:30 Coffee break
15:30-16:45 Concurrent symposium IV
Kidney Transplanation
Concurrent symposium V
Liver Transplanation
Concurrent symposium VI
Coordinator Session


  ³»¿ë ÁÂÀå/¿¬ÀÚ
9:00~9:10 Opening
Symposium I :
Safety of Living Donors
ÁÂÀå: Á¶¿øÇö (°è¸íÀÇ´ë),
ÀÌ½Â±Ô (¿ï»êÀÇ´ë)
9:10~9:35 »ýü ½ÅÀåÀÌ½Ä °ø¿©ÀÚÀÇ ¾ÈÁ¤¼º ÃÖ¼öÁø³ª (Àü³²ÀÇ´ë)
9:35~10:00 »ýü °£ÀÌ½Ä °ø¿©ÀÚÀÇ ¾ÈÁ¤¼º Ȳ ½Å (¿ï»êÀÇ´ë)
Plenary Lecture :
Safety of Living Organ Donors
ÁÂÀå: ±èÇöö (°è¸íÀÇ´ë)
10:00~11:00 Donor safety in living donor kidney transplantation Gabriel Danovitch(UCLA)
11:00~11:20 Coffee Break
Symposium II :
Updates in Transplantation Related Infection
ÁÂÀå: ÇÑ´öÁ¾ (¿ï»êÀÇ´ë),
±è¼®¿µ (°¡Å縯ÀÇ´ë)
11:20~11:37 Fever, Friend or Foe? ±è»óÀÏ (°¡Å縯ÀÇ´ë)
11:37~11:54 Superbacteria, Are there Treatment Options? ¹é°æ¶õ (¼º±Õ°üÀÇ´ë)
11:55~12:12 Emerging Viral Infection in Transplanted patients ¹Ú¿Ï¹ü (¼­¿ïÀÇ´ë)
12:12~12:29 New Diagnostic Methods in Transplant infection ¿ëµ¿Àº (¿¬¼¼ÀÇ´ë)
12:30-12:50 ÀÓ½ÃÃÑȸ
Luncheon Symposium (Genzyme) ÁÂÀå: ÇÑ´öÁ¾(¿ï»êÀÇ´ë)
12:50~13:50 Recent updates in Kidney Transplantation induction wity Thymoglobuline Tatsuo Kawai(Harvard Medical School)
13:50-14:00 Break
Concurrent Symposium I:
Kidney 1-Kidney transplantation and age
ÁÂÀå: ¾È±Ô¸®(¼­¿ïÀÇ´ë),
¹®Àμº(°¡Å縯ÀÇ´ë)
14:00~14:25 Kidney Transplantation to old Recipients ÀÌ ½Ä(ÀüºÏÀÇ´ë)
14:25~14:50 Kidney transplantation from old Donors ¿Àâ±Ç(¾ÆÁÖÀÇ´ë)
14:50~15:15 Current issues in Pediatric Kidney Transplantation °­Èñ°æ (¼­¿ïÀÇ´ë)
Concurrent Symposium II:
Liver 1-ABO-incompatible liver transplantation
ÁÂÀå: À̼®±¸ (¼º±Õ°üÀÇ´ë),
¿ÕÈñÁ¤ (¾ÆÁÖÀÇ´ë)
14:00~14:25 Action Mechanism of Rituximab ±èÅÂÁø (¼º±Õ°üÀÇ´ë)
14:25~14:50 Role of Plasma Exchange ±Ç¼®¿î (¿ï»êÀÇ´ë)
14:50~15:15 Practical Institutional Protocols ¼Û±â¿ø (¿ï»êÀÇ´ë)
Concurrent Symposium III:
Pathology and Diagnostic immunology :
Recent advances in the diagnosis of renal transplant rejection
ÁÂÀå: Á¤»ó¿µ (Àü³²ÀÇ´ë),
Á¤ÇöÁÖ (¿¬¼¼ÀÇ´ë)
14:00~14:25 C4d and Acute Antibody Mediated Rejection ÃÖ¿µÁø (°¡Å縯ÀÇ´ë)
14:25~14:50 C4d and Chronic Antibody Mediated Rejection ÀÓ¹üÁø (¿¬¼¼ÀÇ´ë)
14:50~15:15 Reevaluation of Chronic Allograft Nephropathy Áø¼Ò¿µ (¼øõÇâÀÇ´ë)
15:15-15:30 Coffee Break
Concurrent Symposium IV:
Kidney 2-Debate for choice of immunosuppressants in living donor kidney transplantation
ÁÂÀå: ±èÀ¯¼± (¿¬¼¼ÀÇ´ë),
±Ç¿ÀÁ¤ (ÇѾçÀÇ´ë)
15:30~15:55 Tacrolimus vs. Cyclosporine ±èÁß°æ(ºÀ»ýº´¿ø)
15:55~16:20 Mycophenolate vs. azathioprine/no anti-proliferative agent Á¶È«·¡(¿ï»êÀÇ´ë)
16:20~16:45 Role of mTOR inhibitors ¾çö¿ì(°¡Å縯ÀÇ´ë)
Concurrent Symposium V:
Liver 2 - Renal dysfunction before and after liver transplantation
ÁÂÀå: ±èµ¿±¸(°¡Å縯ÀÇ´ë),
±è¼øÀÏ(¿¬¼¼ÀÇ´ë)
15:30~15:55 Management of hepatorenal syndrome Á¶Àç¿ø (¼º±Õ°üÀÇ´ë)
15:55~16:20 Treatment of early posttransplant renal dysfunction À̳²ÁØ (¼­¿ïÀÇ´ë)
16:20~16:45 Prevention of long-term nephrotoxicity ±è¸í¼ö (¿¬¼¼ÀÇ´ë)
Concurrent Symposium VI:
Coordinator -Transplantation in high immunological risk recipient
ÁÂÀå: Àü°æ¿Á (¼¼ºê¶õ½ºº´¿ø),
º¹ÃáÈñ (Çѱ¹Àå±â±âÁõ¿ø)
15:30~15:55 Positive crossmatch ȯÀÚÀÇ ½ÅÀåÀÌ½Ä ±èÂù´ö(°æºÏÀÇ´ë)
15:55~16:20 ABO incompatible KTx ±èº´Ã¢ (¸Þ¸®³îº´¿ø)
16:20~16:45 ABO incompatible LTx Á¤µ¿È¯ (¿ï»êÀÇ´ë)